Microbot Medical (MBOT) Net Shares Issued and Repurchased (2011 - 2026)
Microbot Medical's (MBOT) quarterly Net Shares Issued and Repurchased came in at $480000.0 in Q1 2026, up 52.93% on a YoY basis from $313875.0 in Q1 2025, and down 48.42% quarter-over-quarter from $930680.0 in Q4 2025.
Powered by 
Analysis
Microbot Medical (MBOT) Net Shares Issued and Repurchased (2011 - 2026) Analysis & Trends
Microbot Medical (MBOT) has reported Net Shares Issued and Repurchased for 16 consecutive years, with $480000.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Net Shares Issued and Repurchased rose 52.93% year-over-year to $480000.0; the trailing twelve-month figure through Mar 2026 stood at $480000.0 (up 52.93% YoY), and the FY2025 full-year result was $930680.0, up 65.58% from the prior year.
- Net Shares Issued and Repurchased retreated to $480000.0 in Q1 2026 per MBOT's latest filing, from $930680.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $930680.0 in Q4 2025 and bottomed at $25000.0 in Q3 2024.
- Historically, Net Shares Issued and Repurchased has averaged $409142.9 across 5 years, with a median of $480000.0 in 2026.
- The sharpest annual moves came in 2023 and 2025: Net Shares Issued and Repurchased plunged 30.0% in 2023, then surged 2837.84% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $530822.0 in 2022, then surged by 34.0% to $711308.0 in 2023, then dropped by 20.98% to $562067.0 in 2024, then soared by 65.58% to $930680.0 in 2025, then slumped by 48.42% to $480000.0 in 2026.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $480000.0, $930680.0, and $734461.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Microbot Medical | 97.38 Mn | 97.38 Mn | 2,000.00 | 480,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 480,000.00 |
| Dec 31, 2025 | 930,680.00 |
| Sep 30, 2025 | 734,461.00 |
| Jun 30, 2025 | 42,359.00 |
| Mar 31, 2025 | 313,875.00 |
| Dec 31, 2024 | 562,067.00 |
| Sep 30, 2024 | 25,000.00 |
| Dec 31, 2023 | 711,308.00 |
| Mar 31, 2023 | 70,000.00 |
| Dec 31, 2022 | 530,822.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 421,426.00 |
| Dec 31, 2020 | 214,145.00 |
| Mar 31, 2020 | 166,666.00 |
| Dec 31, 2019 | 48,893.00 |
| Mar 31, 2019 | 11,630.00 |
| Dec 31, 2018 | 10,000.00 |
| Dec 31, 2017 | 272,090.00 |
| Dec 31, 2016 | 1.45 Mn |
| Sep 30, 2016 | 7,740.00 |